论文部分内容阅读
目的:观察阿奇霉素治疗小儿支原体肺炎的临床疗效。方法:选取2012~2013年就诊的小儿支原体肺炎病例500例,随机分为两组,两组在年龄、性别、病情上无明显差异,其中一组250例为对照组在常规治疗上给予红霉素,另外一组250例在常规治疗基础上给予阿奇霉素,观察两组患者症状好转情况。结果:给予阿奇霉素治疗的患者症状明显好转,总有效率(92.4%),明显高于对照组。结论:阿奇霉素在治疗小儿支原体肺炎中有显著的疗效,副作用较小,值得在临床推广。
Objective: To observe the clinical efficacy of azithromycin in treating children with mycoplasma pneumonia. Methods: A total of 500 children with mycoplasma pneumonia from 2012 to 2013 were selected and randomly divided into two groups. There was no significant difference in age, sex and disease between the two groups. One group of 250 cases were given routine treatment with erythromycin Another group of 250 cases of azithromycin given on the basis of conventional treatment, observed two groups of patients improved symptoms. Results: The symptoms of patients treated with azithromycin improved significantly. The total effective rate (92.4%) was significantly higher than that of the control group. Conclusion: Azithromycin in the treatment of children with mycoplasma pneumonia have a significant effect, less side effects, it is worth in the clinical promotion.